scholarly journals Emergence of mupirocin resistance in multiresistant Staphylococcus aureus clinical isolates belonging to Brazilian epidemic clone III::B:A

1999 ◽  
Vol 48 (3) ◽  
pp. 303-307 ◽  
Author(s):  
R.L.B. RAMOS ◽  
L.A. TEIXEIRA ◽  
L.R. ORMONDE ◽  
P.L.A. SIQUEIRA ◽  
M.S. SANTOS ◽  
...  
2016 ◽  
Vol 145 (2) ◽  
pp. 386-396 ◽  
Author(s):  
C. HORNER ◽  
L. UTSI ◽  
L. COOLE ◽  
M. DENTON

SUMMARYWe investigated the epidemiology and characterization of isolates of Staphylococcus aureus within the Yorkshire and Humber (YH) region in the UK. In July 2015, each laboratory within YH (n = 14) was assigned two consecutive days during which all clinical isolates of S. aureus were collected. Isolates were tested for antibiotic susceptibilities and the presence of genes encoding methicillin resistance (mecA and mecC), Panton–Valentine leukocidin (PVL) (lukS-PV), and efflux-mediated chlorhexidine resistance (qacA); isolates were also characterized by spa-types. Minimum inhibitory concentrations (MICs) to chlorhexidine were determined by the broth dilution method. Of 520 isolates collected, 6·2% were methicillin-resistant S. aureus (MRSA, all mecA-positive) and mupirocin resistance was low [0·8%, 95% confidence interval (CI) 0·3–2·0] and only found in MRSA. Carriage of the qacA gene was identified in 1·7% (95% CI 0·8–3·3) of isolates and 3·5% (95% CI 2·2–5·4) had a chlorhexidine MIC of 4 mg/l. The PVL gene was infrequent (3·7%, 95% CI 2·4–5·6). Genotyping identified 234 spa-types that mapped to 22 clonal complexes. Comparison of these current data with previous work suggest that the widespread use of staphylococcal decolonization regimens over the past decade or more has not had an adverse impact on resistance rates, PVL carriage or the prevalence of specific S. aureus lineages.


Oncotarget ◽  
2017 ◽  
Vol 8 (35) ◽  
pp. 58086-58097 ◽  
Author(s):  
Xingmei Liu ◽  
Shanshan Deng ◽  
Jinwei Huang ◽  
Yaling Huang ◽  
Yu Zhang ◽  
...  

2003 ◽  
Vol 24 (4) ◽  
pp. 300-301 ◽  
Author(s):  
Paula G. Jones ◽  
Terri Sura ◽  
Michael Harris ◽  
Anne Strother

AbstractOne hundred isolates of Staphylococcus aureus were collected in a laboratory serving several hospitals and clinics in southeastern Wisconsin and tested for mupirocin susceptibility. Only two isolates of S. aureus showed mupirocin resistance. The mupirocin-resistant isolates were from hospitalized patients with positive blood cultures.


2021 ◽  
Vol 11 (0) ◽  
pp. 2
Author(s):  
G. A. Achintha ◽  
D. S. S. D. Rupasena ◽  
S. M. D. I. Pathum ◽  
C. P. Gunasekara ◽  
H. Kulathunga ◽  
...  

JMS SKIMS ◽  
2019 ◽  
Vol 22 (3) ◽  
Author(s):  
Nargis Bali ◽  
Maroof Peer ◽  
Roseleen Kour ◽  
Suhail Ahmad ◽  
Parvaiz Koul

Background: Staphylococcus aureus continues to be major healthcare problem worldwide as therapeutic options for its management are limited. Decolonisation regimes using mupiroicin are aimed at reducing the burden of infection due to this microorganism. However resistance to mupirocin poses a threat to the current standard eradication protocols.Aims: To find out the type and extent of mupirocin resistance in clinical isolates of S. aureus. Material and methods: This cross-sectional study was carried out at a tertiary care centre of North India for a period of 6 months. S. aureus recovered by standard microbiological procedures form various clinical samples such as blood, urine, pus and other body fluids was subjected to antimicrobial susceptibility testing along with detection of mupirocin resistance using 5 and 200µg discs. Minimum inhibitory concentration (MIC) of mupirocin was determined using E -test strips. Fisher’s exact test was done to determine the statistical significance. A P-value of <0.05 was considered as statistically significant.Results: A total of 247 S. aureus isolates were recovered of which 81 (32.8%) were resistant to methicillin (MRSA) whereas 166 (67.2%) were sensitive to this antibiotic (MSSA). Low level resistance to mupirocin was seen in 7 (8.6%) MRSA and 3 (1.8%) MSSA isolates. Prior use of this topical antibiotic and previous hospitalisation were found to be the risk factors associated with mupirocin resistance. Conclusion: Low level mupirocin resistance was seen in S. aureus isolates which if left unchecked could in future pave way for high level resistance and subsequent treatment failures.


Sign in / Sign up

Export Citation Format

Share Document